GJD2 and ischemia: Our previous studies showed that genetic or pharmacological blockade of neuronal (Cx36-containing) gap junctions prevents NMDAR-mediated excitotoxicity [14, 18, 19] and dramatically reduces neuronal death caused by ischemia and TBI [6, 15].